Tested Applications
| Positive WB detected in | Jurkat cells, HepG2 cells |
| Positive IHC detected in | human liver cancer tissue, human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | MCF-7 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
16371-1-AP targets GTPBP9 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag9283 Product name: Recombinant human OLA1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-250 aa of BC013925 Sequence: MPPKKGGDGIKPPPIIGRFGTSLKIGIVGLPNVGKSTFFNVLTNSQASAENFPFCTIDPNESRVPVPDERFDFLCQYHKPASKIPAFLNVVDIAGLVKGAHNGQGLGNAFLSHISACDGIFHLTRAFEDDDITHVEGSVDPIRDIEIIHEELQLKDEEMIGPIIDKLEKVAVRGGDKKLKPEYDIMCKVKSWVIDQKKPVRFYHDWNDKEIEVLNKHLFLTSKPMVYLVNLSEKDYIRKKNKWLLESTDN Predict reactive species |
| Full Name | Obg-like ATPase 1 |
| Calculated Molecular Weight | 396aa,45 kDa; 278aa,31 kDa |
| Observed Molecular Weight | 45 kDa |
| GenBank Accession Number | BC013925 |
| Gene Symbol | OLA1 |
| Gene ID (NCBI) | 29789 |
| RRID | AB_2157087 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NTK5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for GTPBP9 antibody 16371-1-AP | Download protocol |
| IHC protocol for GTPBP9 antibody 16371-1-AP | Download protocol |
| WB protocol for GTPBP9 antibody 16371-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The GTPBP9 (OLA1) Polyclonal antibody (Cat# 16371-1-AP) has 6 citations published in iScience, J Cell Sci, PLoS One, Clin Exp Pharmacol Physiol, bioRxiv, and medRxiv. The cited research spans cardiovascular disease (dilated cardiomyopathy, hypertrophic response, failing heart), viral immunology (HIV-1/STING pathway), and gut microbiota–related arrhythmia, with applications primarily in Western blot and immunofluorescence in human and mouse models.
| Species | Application | Title |
|---|---|---|
J Cell Sci HIV-1 p17 matrix protein enhances type I interferon responses through the p17-OLA1-STING axis
| ||
PLoS One Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart | ||
Clin Exp Pharmacol Physiol OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
| ||
medRxiv Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart | ||
bioRxiv Obg-like ATPase 1 Genetic Deletion Leads to Dilated Cardiomyopathy in Mice and Structural Changes in Drosophila Heart |
Reviews
What customers say
Both reviews rate the product 5 stars for Western Blot. One user tested it on AC16 cells at a 1:1000 dilution and described the result as "excellent." The other user tested it on H9C2 cells at a 1:3000 dilution and rated it "Good." Overall, customers report strong performance and reliable band detection in WB applications across different cell types and dilutions.
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
S (Verified Customer) (03-20-2023) | excellent
![]() |
p (Verified Customer) (05-27-2021) | Good
![]() |

















